Risk factors for coronary heart disease and survival after myocardial infarction

Sjoerd T Nauta1, Jaap W Deckers, Robert M van der Boon

  • 1Thoraxcentre, Erasmus Medical Centre, Rotterdam, The Netherlands.

Insights

Patients with coronary heart disease risk factors experienced better survival after myocardial infarction. These individuals saw greater mortality reductions over recent decades, highlighting the importance of managing risk factors.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Coronary heart disease (CHD) risk factors are often linked to adverse health outcomes.
  • A paradoxical association has been observed between CHD risk factors and improved in-hospital survival post-myocardial infarction (MI).

Purpose of the Study:

  • To confirm the paradox of improved survival in MI patients with CHD risk factors.
  • To determine if this survival benefit extends to long-term outcomes.
  • To investigate temporal trends in mortality rates over time.

Main Methods:

  • Analysis of 14,434 patients admitted with MI between 1985 and 2008.
  • Examined the association between four modifiable CHD risk factors (hypertension, dyslipidaemia, diabetes, smoking) and mortality.
  • Utilized survival analysis to assess 30-day and 10-year mortality rates.

Main Results:

  • Two-thirds of MI patients possessed at least one CHD risk factor.
  • The presence of at least one risk factor was linked to a favorable 30-day mortality rate (5% vs. 7%).
  • While the 10-year mortality hazard ratio (HR) initially favored those without risk factors (1.2 in 1985-1990), it became similar or favorable in later periods (0.89 in 2000-2008).
  • Significant improvements in 10-year survival were observed over time, particularly for patients with CHD risk factors.

Conclusions:

  • The presence of modifiable CHD risk factors is associated with improved outcomes following MI.
  • Patients with CHD risk factors have experienced more substantial reductions in mortality over recent decades.
  • Managing CHD risk factors remains crucial for improving long-term prognosis after myocardial infarction.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...